Medikinet

Methylphenidate Hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as a tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults by increasing dopamine and norepinephrine concentrations in the brain, which helps improve focus and reduce excessive daytime sleepiness.

GNH USA supplies Medikinet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Medikinet is a central nervous system stimulant indicated for disorders that affect attention and wakefulness.

- Attention deficit hyperactivity disorder (children and adolescents): improves attention, reduces hyperactivity and impulsivity. - Attention deficit hyperactivity disorder (adults): enhances focus and reduces distractibility. - Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced desire for food, potentially leading to weight loss. - Headache: mild to moderate head pain. - Stomach pain: abdominal discomfort or cramps.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, tachycardia, or arrhythmia. - Psychosis: emergence of hallucinations or delusional thinking. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor cardiovascular status: assess blood pressure and heart rate regularly. - Assess psychiatric history: watch for emergence of psychotic or manic symptoms. - Avoid use in patients with severe anxiety: the stimulant may exacerbate anxiety. - Do not co‑administer with monoamine oxidase inhibitors: risk of hypertensive crisis. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Methylphenidate may interact with other medicines, requiring caution.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: can cause hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular side effects. - Antihypertensive agents: may reduce the efficacy of blood pressure control.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors: may raise methylphenidate plasma levels. - Alcohol: can enhance central nervous system effects and increase sedation.